Application 214831
- Type
- ANDA
- Sponsor
- ANNORA PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | BRIVARACETAM | BRIVARACETAM | TABLET; ORAL | 25mg | No | No |
| 003 | BRIVARACETAM | BRIVARACETAM | TABLET; ORAL | 50mg | No | No |
| 004 | BRIVARACETAM | BRIVARACETAM | TABLET; ORAL | 75mg | No | No |
| 005 | BRIVARACETAM | BRIVARACETAM | TABLET; ORAL | 100mg | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| brivaracetam | BRIVARACETAM | Zydus Pharmaceuticals USA Inc. | d54ca946-2ddf-4a67-87c9-20a814bfd2dc | 2026-01-27 | Warnings, Adverse reactions | brivaracetam BRIVARACETAM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.